Combined effects of panipenem and aminoglycosides on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in vitro

被引:4
作者
Katou, K [1 ]
Nakamura, A [1 ]
Kato, T [1 ]
Tonegawa, K [1 ]
Kutsuna, T [1 ]
Niwa, T [1 ]
Morita, H [1 ]
Itoh, M [1 ]
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Internal Med & Bioregulat, Mizuho Ku, Aichi 4678601, Japan
关键词
panipenem; fractional inhibitory concentration; antimicrobial combinations; Pseudomonas aeruginosa; methicillin-resistant Staphylococcus aureus (MRSA);
D O I
10.1159/000088969
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa are the main causes of refractory infections that are often resistant to antimicrobial agents. In these cases, combination of agents with antimicrobial activity is being examined. However, few studies have investigated combined effects with antimicrobial agents including carbapenem and aminoglycosides. Methods: We evaluated the effects of panipenem ( PAPM) combined with 3 aminoglycosides, arbekacin, amikacin, and netilmicin, and vancomicin (VCM) with an agar dilution checkerboard technique and the fractional inhibitory concentration index against 47 strains of MRSA and 56 strains of P. aeruginosa. Results: PAPM combined with VCM achieved a synergic effect against MRSA in 80.9%. PAPM combined with aminoglycosides showed only additive effects against MRSA and P. aeruginosa. When comparing the activity of Mueller-Hinton agar (MHA) medium with MHA medium diluted 40-fold (1/40 MHA) against P. aeruginosa, the mean minimum inhibitory concentration of PAPM was decreased to 1/16. Conclusions: Combination of PAPM and VCM is effective against MRSA. Combinations of PAPM and aminoglycosides showed additive effects against MRSA and P. aeruginosa. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:387 / 391
页数:5
相关论文
共 15 条
[1]   BACTERICIDAL ACTIVITY OF MEROPENEM AND INTERACTIONS WITH OTHER ANTIBIOTICS [J].
FERRARA, A ;
GRASSI, G ;
GRASSI, FA ;
PICCIONI, PD ;
GRASSI, GG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 :239-250
[2]   IN-VITRO ACTIVITIES OF VARIOUS ANTIBIOTICS, ALONE AND IN COMBINATION WITH AMIKACIN AGAINST PSEUDOMONAS-AERUGINOSA [J].
GERCEKER, AA ;
GURLER, B .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (04) :707-711
[3]  
Goto S.K., 1981, Chemotherapy, V29, P76
[4]   DECREASES OF THE SUSCEPTIBILITY TO LOW-MOLECULAR-WEIGHT BETA-LACTAM ANTIBIOTICS IN IMIPENEM-RESISTANT PSEUDOMONAS-AERUGINOSA MUTANTS - ROLE OF OUTER-MEMBRANE PROTEIN-D2 IN THEIR DIFFUSION [J].
GOTOH, N ;
NISHINO, T .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (02) :191-198
[5]   MEASUREMENT OF POTENCIES OF DRUG MIXTURES [J].
HEWLETT, PS .
BIOMETRICS, 1969, 25 (03) :477-&
[6]   Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [J].
Hiramatsu, K ;
Aritaka, N ;
Hanaki, H ;
Kawasaki, S ;
Hosoda, Y ;
Hori, S ;
Fukuchi, Y ;
Kobayashi, I .
LANCET, 1997, 350 (9092) :1670-1673
[7]  
JAWETZ E, 1952, J BACTERIOL, V1, P29
[8]   Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolates [J].
Muramatsu, H ;
Horii, T ;
Morita, M ;
Hashimoto, H ;
Kanno, T ;
Maekawa, M .
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2003, 293 (2-3) :191-197
[9]   Combined effects of meropenem and aminoglycosides on Pseudomonas aeruginosa in vitro [J].
Nakamura, A ;
Hosoda, M ;
Kato, T ;
Yamada, Y ;
Itoh, M ;
Kanazawa, K ;
Nouda, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :901-904
[10]  
Nakazawa Hiroaki, 2003, Journal of Infection and Chemotherapy, V9, P304, DOI 10.1007/s10156-003-0266-2